CSIMarket Company Name, Ticker, Industry, else..


Stoke Therapeutics Inc   (NASDAQ: STOK)
Other Ticker:  
 

Stoke Therapeutics Inc

STOK's Fundamental analysis



Looking into Stoke Therapeutics Inc growth rates, revenue grew by 707.35 % in the fourth quarter of 2024 from the same quarter a year ago. Ranking at No. 2166

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Stoke Therapeutics Inc net loss decreased from $-27 millions, to $-10 millions in fourth quarter of 2024,

• More on STOK's Growth


Stoke Therapeutics Inc
realized a net loss in trailing twelve months.

Stoke Therapeutics Inc realized cash reduction of $ -1.17 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.25.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.


• More on STOK's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 285,586
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 4.25

Stoke Therapeutics Inc
realized net loss in trailing twelve months.

Stoke Therapeutics Inc realized cash outflow of $ -1.17per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.25.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.

Stoke Therapeutics Inc Price to Book Ratio is at 2.27 lower than Industry Avg. of 78.2. and higher than S&P 500 Avg. of 0.01

• More on STOK's Valuation

•  Market Capitalization (Millions $) 521
•  Shares Outstanding (Millions) 54
•  Employees 128
•  Revenues (TTM) (Millions $) 37
•  Net Income (TTM) (Millions $) -89
•  Cash Flow (TTM) (Millions $) -63
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 285,586
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 4.25

•  Market Capitalization (Millions $) 521
•  Shares Outstanding (Millions) 54
•  Employees 128
•  Revenues (TTM) (Millions $) 37
•  Net Income (TTM) (Millions $) -89
•  Cash Flow (TTM) (Millions $) -63
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 10.83
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.1
•  Asset Turnover Ratio (TTM) 0.14
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com